BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37635070)

  • 1. Ataxia Telangiectasia in a Patient with Breast Cancer: A Case Report.
    Mizuno M; Ohnuki Y; Unzaki A; Suzuki M; Takeshita K; Takahashi S; Kiyohara H; Nakagawa S; Ishida R; Yokoyama K; Terao M; Okamura T; Hanamura T; Niikura N
    Tokai J Exp Clin Med; 2023 Sep; 48(3):95-98. PubMed ID: 37635070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and Emerging Therapies for HER2-Positive Women With Metastatic Breast Cancer.
    Porter K; Rosenzweig MQ
    J Adv Pract Oncol; 2017 Mar; 8(2):164-168. PubMed ID: 29900024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conversion Therapy for HER2-Positive Metastatic Breast Cancer with Intrathoracic Lymph Node Metastasis].
    Kono H; Maeda H; Yao S; Takahashi M; Yokoi S; Goi T; Imamura Y
    Gan To Kagaku Ryoho; 2020 Jun; 47(6):977-980. PubMed ID: 32541178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Postmastectomy Radiotherapy in Locally Advanced Breast Cancer After Pathological Complete Response to Neoadjuvant Chemotherapy.
    Flores-Balcázar CH; Castro-Alonso FJ; Hernández-Barragán TP; Delgado-de la Mora J; Daidone A; Trejo-Durán GE
    Oncology (Williston Park); 2021 Mar; 35(3):139-143. PubMed ID: 33818049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy].
    Katsuta E; Ohkubo T; Someno Y; Saguchi M; Aoyagi H; Takahata T; Hasegawa K; Hamada S; Kaneko J; Maejima S
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2760-2. PubMed ID: 21224704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary neuroendocrine tumors of the breast: two case reports and review of the literature.
    Hejjane L; Oualla K; Bouchbika Z; Bourhafour M; Lhlou Mimi A; Boubacar E; Benider A; Benbrahim Z; Aarifi S; Mellas N
    J Med Case Rep; 2020 Mar; 14(1):41. PubMed ID: 32156307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenocarcinoma of the Breast Presenting as Occult Breast Cancer With Axillary and Supraclavicular Lymph Node Metastasis: A Case Report.
    Aleman Espino A; Bernal IC; Guarecuco JE; El-Tawil R; Masri MM
    Cureus; 2023 May; 15(5):e39583. PubMed ID: 37384084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pregnancy associated breast cancer].
    Székely B; Langmár Z; Somlai K; Szentmártoni G; Szalay K; Korompay A; Szász AM; Kulka J; Bánhidy F; Dank M
    Orv Hetil; 2010 Aug; 151(32):1299-303. PubMed ID: 20656670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].
    Ohsako T; Inoue K; Nagamoto N; Yoshida Y; Nakahara O
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1301-3. PubMed ID: 16969029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-Term Effect of Fulvestrant for Locally Advanced Breast Cancer in an Elderly Patient - A Case Report].
    Sakurai K; Fujisaki S; Kubota H; Hara Y; Suzuki S; Adachi K; Tomita R; Enomoto K; Hirano T
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):76-78. PubMed ID: 29362313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neuroendocrine Carcinoma of the Breast Encountered in the General Hospital without the Breast Department-A Case Report].
    Sakurai K; Fujisaki S; Kubota H; Suzuki Y; Adachi K; Suzuki S; Hirano T; Tomita R
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1904-1906. PubMed ID: 30692393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative genic switch of HER-2 in the primary tumor instead of the synchronous metastatic nodal lesions after neoadjuvant chemotherapy in a patient with primary HER2-positive breast cancer.
    Chen HR; Wu YT; Yu QB; Yang YY; Wei YX; Li HY; Wu KN; Kong LQ
    World J Surg Oncol; 2017 Oct; 15(1):189. PubMed ID: 29052527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The case of a long-surviving patient with breast cancer and brain metastases treated using multidisciplinary therapy].
    Nishimura A; Nishi T; Morohashi S; Okano K; Hakamada K
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1897-9. PubMed ID: 25731368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of breast cancer in countries with limited resources.
    Carlson RW; Anderson BO; Chopra R; Eniu AE; Jakesz R; Love RR; Masetti R; Schwartsmann G;
    Breast J; 2003; 9 Suppl 2():S67-74. PubMed ID: 12713499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Occult Breast Carcinoma and Recurrent Tumor in the Breast 14 Years after Axillary Dissection-A Case Report].
    Fujimori T; Kasagawa T; Ishii N; Kusashio K; Ozaki D
    Gan To Kagaku Ryoho; 2019 Dec; 46(13):2249-2251. PubMed ID: 32156894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
    Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
    JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.